AR081150A1 - La aplicacion de bacterias del acido lactico para el tratamiento o la prevencion de la rinitis - Google Patents

La aplicacion de bacterias del acido lactico para el tratamiento o la prevencion de la rinitis

Info

Publication number
AR081150A1
AR081150A1 ARP110100460A ARP110100460A AR081150A1 AR 081150 A1 AR081150 A1 AR 081150A1 AR P110100460 A ARP110100460 A AR P110100460A AR P110100460 A ARP110100460 A AR P110100460A AR 081150 A1 AR081150 A1 AR 081150A1
Authority
AR
Argentina
Prior art keywords
lactobacillus rhamnosus
rhinitis
formula
prevention
treatment
Prior art date
Application number
ARP110100460A
Other languages
English (en)
Spanish (es)
Original Assignee
Salmon Bernadette
Wickens Kristin Lee
Stanley Thorstem Villiers
Fitzharris Penelope Frances
Crane Julian
Mitchell Edwin Arthur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salmon Bernadette, Wickens Kristin Lee, Stanley Thorstem Villiers, Fitzharris Penelope Frances, Crane Julian, Mitchell Edwin Arthur filed Critical Salmon Bernadette
Publication of AR081150A1 publication Critical patent/AR081150A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/02Making cheese curd
    • A23C19/032Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP110100460A 2010-02-15 2011-02-15 La aplicacion de bacterias del acido lactico para el tratamiento o la prevencion de la rinitis AR081150A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ58329810 2010-02-15

Publications (1)

Publication Number Publication Date
AR081150A1 true AR081150A1 (es) 2012-07-04

Family

ID=44367953

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100460A AR081150A1 (es) 2010-02-15 2011-02-15 La aplicacion de bacterias del acido lactico para el tratamiento o la prevencion de la rinitis

Country Status (3)

Country Link
AR (1) AR081150A1 (fr)
TW (1) TW201201820A (fr)
WO (1) WO2011099875A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010064930A1 (fr) 2008-11-28 2010-06-10 Julian Crane Utilisation de bactéries lactiques pour traiter ou prévenir l’eczéma
EP3592363A1 (fr) 2017-03-08 2020-01-15 N.V. Nutricia Composition comprenant des oligosaccharides non digestibles pour atténuer une inflammation épithéliale nasale
CN111139204B (zh) * 2020-01-21 2023-04-14 上海城建职业学院 一种益生菌菌剂及其制备方法和应用
CN113785985A (zh) * 2021-09-18 2021-12-14 中盐工程技术研究院有限公司 一种益生菌组合物、其制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ536894A (en) * 2000-08-08 2006-04-28 Vialactia Bioscience Nz Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
AU2003288826A1 (en) * 2003-12-15 2005-06-29 Fonterra Co-Operative Group Limited Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
WO2010064930A1 (fr) * 2008-11-28 2010-06-10 Julian Crane Utilisation de bactéries lactiques pour traiter ou prévenir l’eczéma

Also Published As

Publication number Publication date
TW201201820A (en) 2012-01-16
WO2011099875A1 (fr) 2011-08-18

Similar Documents

Publication Publication Date Title
PH12020550069A1 (en) Process for purifying sialylated oligosaccharides
CY1117183T1 (el) Διακλαδισμενα παραγωγα 3-φαινυλοπροπιονικου οξεος και η χρηση τους
MX2014004719A (es) Composicion para su uso en la promocion de la angiogenesis intestinal y de la absorcion de nutrientes y de tolerancia a la alimentacion enteral y/o en la prevencion y/o en el tratamiento de la inflamacion intestinal y/o en la recuperacion posterior a un daño o cirugia intestinal.
EA201390305A1 (ru) Композиции для влагалищного и перорального введения lactobacillus и их применение
WO2009033793A3 (fr) Utilisation d'un peptide en tant qu'agent thérapeutique
MY177636A (en) Use of lactic acid bacteria to treat or prevent eczema
MX2015004290A (es) Formulacion que contiene virus y uso de la misma.
BR112015000136A2 (pt) fibra alimentar para uso no tratamento de um efeito colateral gastrintestinal de uma nutrição ou medicamento
WO2015177246A3 (fr) Supplémentation en microbiome néonatal
WO2009039991A3 (fr) Utilisation d'un peptide en tant qu'agent thérapeutique
AR081150A1 (es) La aplicacion de bacterias del acido lactico para el tratamiento o la prevencion de la rinitis
RU2014106509A (ru) Получение и применение бактериального гистамина
NZ594184A (en) Skin treatment
BR112015028164A2 (pt) probióticos e métodos de uso
PH12015502517A1 (en) Compositions and methods for nutrient delivery
BR112013026644A2 (pt) método para a modulação da atividade de citocina
MY173927A (en) Formula fortifier
HRP20230639T1 (hr) Pripravak koji sadrži lactobacillus reuteri i citrat za medicinsku primjenu
MX2013006128A (es) Nuevo compuesto y uso medico del mismo.
MX355787B (es) Cepas de lactococcus lactis y preparaciones bacterianas de las mismas, para la producción de péptidos bioactivos que tienen efectos antihipertensivos y de disminución de colesterol en mamíferos; productos nutricionales y terapéuticos producidos a partir de los mismos.
PE20130308A1 (es) Metodos para tratar infecciones bacterianas recurrentes
RU2013133998A (ru) Способы и композиции для предотвращения и лечения остеоартрита
MX342391B (es) Composiciones y metodos para el suministro de nutrientes.
JP2015533484A5 (fr)
WO2018078599A3 (fr) Composition pour le traitement préventif ou curatif de troubles hépatiques

Legal Events

Date Code Title Description
FB Suspension of granting procedure